Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MLSS vs NVST vs XRAY vs ALGN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MLSS
Milestone Scientific Inc.

Medical - Instruments & Supplies

HealthcareAMEX • US
Market Cap$37M
5Y Perf.-75.2%
NVST
Envista Holdings Corp

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$4.04B
5Y Perf.+14.7%
XRAY
DENTSPLY SIRONA Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$2.20B
5Y Perf.-76.4%
ALGN
Align Technology, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$12.06B
5Y Perf.-31.3%

MLSS vs NVST vs XRAY vs ALGN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MLSS logoMLSS
NVST logoNVST
XRAY logoXRAY
ALGN logoALGN
IndustryMedical - Instruments & SuppliesMedical - Equipment & ServicesMedical - Instruments & SuppliesMedical - Devices
Market Cap$37M$4.04B$2.20B$12.06B
Revenue (TTM)$9M$2.81B$3.68B$4.10B
Net Income (TTM)$-7M$68M$-628M$430M
Gross Margin72.8%55.1%48.9%67.7%
Operating Margin-77.0%9.0%4.1%14.4%
Forward P/E17.0x7.7x14.8x
Total Debt$349K$1.71B$2.47B$114M
Cash & Equiv.$3M$1.21B$326M$1.08B

MLSS vs NVST vs XRAY vs ALGNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MLSS
NVST
XRAY
ALGN
StockMay 20May 26Return
Milestone Scientifi… (MLSS)10024.8-75.2%
Envista Holdings Co… (NVST)100114.7+14.7%
DENTSPLY SIRONA Inc. (XRAY)10023.6-76.4%
Align Technology, I… (ALGN)10068.7-31.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: MLSS vs NVST vs XRAY vs ALGN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NVST and XRAY are tied at the top with 2 categories each — the right choice depends on your priorities. DENTSPLY SIRONA Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. ALGN and MLSS also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
MLSS
Milestone Scientific Inc.
The Income Pick

MLSS is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 0.94
  • Lower volatility, beta 0.94, Low D/E 6.0%, current ratio 2.48x
  • Beta 0.94, current ratio 2.48x
  • Beta 0.94 vs XRAY's 1.78, lower leverage
Best for: income & stability and sleep-well-at-night
NVST
Envista Holdings Corp
The Growth Play

NVST has the current edge in this matchup, primarily because of its strength in growth exposure.

  • Rev growth 8.3%, EPS growth 104.3%, 3Y rev CAGR 1.9%
  • 8.3% revenue growth vs MLSS's -12.2%
  • +44.2% vs MLSS's -48.5%
Best for: growth exposure
XRAY
DENTSPLY SIRONA Inc.
The Value Play

XRAY is the #2 pick in this set and the best alternative if value and dividends is your priority.

  • Lower P/E (7.7x vs 14.8x)
  • 5.9% yield; 23-year raise streak; the other 3 pay no meaningful dividend
Best for: value and dividends
ALGN
Align Technology, Inc.
The Long-Run Compounder

ALGN is the clearest fit if your priority is long-term compounding.

  • 122.8% 10Y total return vs NVST's -13.1%
  • 10.5% margin vs MLSS's -76.8%
  • 6.9% ROA vs MLSS's -86.6%, ROIC 15.4% vs -121.3%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthNVST logoNVST8.3% revenue growth vs MLSS's -12.2%
ValueXRAY logoXRAYLower P/E (7.7x vs 14.8x)
Quality / MarginsALGN logoALGN10.5% margin vs MLSS's -76.8%
Stability / SafetyMLSS logoMLSSBeta 0.94 vs XRAY's 1.78, lower leverage
DividendsXRAY logoXRAY5.9% yield; 23-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)NVST logoNVST+44.2% vs MLSS's -48.5%
Efficiency (ROA)ALGN logoALGN6.9% ROA vs MLSS's -86.6%, ROIC 15.4% vs -121.3%

MLSS vs NVST vs XRAY vs ALGN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MLSSMilestone Scientific Inc.
FY 2015
Handpieces
100.0%$6M
NVSTEnvista Holdings Corp
FY 2024
Specialty Products and Technologies
64.4%$1.6B
Equipment and Consumables
35.6%$894M
XRAYDENTSPLY SIRONA Inc.
FY 2022
Technologies And Equipment
59.1%$2.3B
Consumables Segment
40.9%$1.6B
ALGNAlign Technology, Inc.
FY 2025
Clear Aligner
80.4%$3.2B
Scanners And Services
19.6%$790M

MLSS vs NVST vs XRAY vs ALGN — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALGNLAGGINGMLSS

Income & Cash Flow (Last 12 Months)

ALGN leads this category, winning 3 of 6 comparable metrics.

ALGN is the larger business by revenue, generating $4.1B annually — 450.9x MLSS's $9M. ALGN is the more profitable business, keeping 10.5% of every revenue dollar as net income compared to MLSS's -76.8%. On growth, MLSS holds the edge at +25.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
RevenueTrailing 12 months$9M$2.8B$3.7B$4.1B
EBITDAEarnings before interest/tax-$7M$342M$424M$790M
Net IncomeAfter-tax profit-$7M$68M-$628M$430M
Free Cash FlowCash after capex-$5M$220M$104M$717M
Gross MarginGross profit ÷ Revenue+72.8%+55.1%+48.9%+67.7%
Operating MarginEBIT ÷ Revenue-77.0%+9.0%+4.1%+14.4%
Net MarginNet income ÷ Revenue-76.8%+2.4%-17.1%+10.5%
FCF MarginFCF ÷ Revenue-57.9%+7.8%+2.8%+17.5%
Rev. Growth (YoY)Latest quarter vs prior year+25.3%+14.4%+0.1%+6.2%
EPS Growth (YoY)Latest quarter vs prior year+130.0%-150.0%+23.6%
ALGN leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

XRAY leads this category, winning 3 of 6 comparable metrics.

At 29.8x trailing earnings, ALGN trades at a 66% valuation discount to NVST's 86.7x P/E. On an enterprise value basis, XRAY's 7.2x EV/EBITDA is more attractive than ALGN's 13.9x.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
Market CapShares × price$37M$4.0B$2.2B$12.1B
Enterprise ValueMkt cap + debt − cash$34M$4.5B$4.3B$11.1B
Trailing P/EPrice ÷ TTM EPS-7.94x86.73x-3.65x29.80x
Forward P/EPrice ÷ next-FY EPS est.16.97x7.75x14.84x
PEG RatioP/E ÷ EPS growth rate58.08x
EV / EBITDAEnterprise value multiple13.28x7.18x13.92x
Price / SalesMarket cap ÷ Revenue4.27x1.49x0.60x2.99x
Price / BookPrice ÷ Book value/share6.42x1.32x1.63x3.02x
Price / FCFMarket cap ÷ FCF17.54x21.11x24.57x
XRAY leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ALGN leads this category, winning 8 of 9 comparable metrics.

ALGN delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for MLSS. ALGN carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to XRAY's 1.84x. On the Piotroski fundamental quality scale (0–9), NVST scores 7/9 vs MLSS's 4/9, reflecting strong financial health.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
ROE (TTM)Return on equity-2.1%+2.2%-41.2%+10.7%
ROA (TTM)Return on assets-86.6%+1.2%-11.2%+6.9%
ROICReturn on invested capital-121.3%+4.8%+5.1%+15.4%
ROCEReturn on capital employed-94.2%+4.9%+6.1%+14.5%
Piotroski ScoreFundamental quality 0–94767
Debt / EquityFinancial leverage0.06x0.55x1.84x0.03x
Net DebtTotal debt minus cash-$3M$496M$2.1B-$965M
Cash & Equiv.Liquid assets$3M$1.2B$326M$1.1B
Total DebtShort + long-term debt$349,054$1.7B$2.5B$114M
Interest CoverageEBIT ÷ Interest expense12.76x-5.12x389.13x
ALGN leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NVST leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in NVST five years ago would be worth $5,340 today (with dividends reinvested), compared to $1,914 for MLSS. Over the past 12 months, NVST leads with a +44.2% total return vs MLSS's -48.5%. The 3-year compound annual growth rate (CAGR) favors NVST at -11.3% vs XRAY's -32.6% — a key indicator of consistent wealth creation.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
YTD ReturnYear-to-date+61.7%+12.0%-2.8%+7.9%
1-Year ReturnPast 12 months-48.5%+44.2%-16.4%-2.2%
3-Year ReturnCumulative with dividends-37.5%-30.3%-69.4%-45.0%
5-Year ReturnCumulative with dividends-80.9%-46.6%-80.1%-71.9%
10-Year ReturnCumulative with dividends-79.9%-13.1%-74.5%+122.8%
CAGR (3Y)Annualised 3-year return-14.5%-11.3%-32.6%-18.1%
NVST leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MLSS and ALGN each lead in 1 of 2 comparable metrics.

MLSS is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than XRAY's 1.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALGN currently trades 80.8% from its 52-week high vs MLSS's 44.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
Beta (5Y)Sensitivity to S&P 5000.85x1.63x1.70x1.65x
52-Week HighHighest price in past year$1.05$30.42$17.18$208.31
52-Week LowLowest price in past year$0.22$16.33$9.85$122.00
% of 52W HighCurrent price vs 52-week peak+44.7%+79.8%+63.8%+80.8%
RSI (14)Momentum oscillator 0–10072.655.139.244.6
Avg Volume (50D)Average daily shares traded2.3M2.4M4.2M1.1M
Evenly matched — MLSS and ALGN each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: NVST as "Hold", XRAY as "Hold", ALGN as "Buy". Consensus price targets imply 25.5% upside for XRAY (target: $14) vs 13.0% for NVST (target: $27). XRAY is the only dividend payer here at 5.86% yield — a key consideration for income-focused portfolios.

MetricMLSS logoMLSSMilestone Scienti…NVST logoNVSTEnvista Holdings …XRAY logoXRAYDENTSPLY SIRONA I…ALGN logoALGNAlign Technology,…
Analyst RatingConsensus buy/hold/sellHoldHoldBuy
Price TargetConsensus 12-month target$27.44$13.75$203.60
# AnalystsCovering analysts193133
Dividend YieldAnnual dividend ÷ price+5.9%
Dividend StreakConsecutive years of raises23
Dividend / ShareAnnual DPS$0.64
Buyback YieldShare repurchases ÷ mkt cap0.0%+4.1%0.0%+3.9%
Insufficient data to determine a leader in this category.
Key Takeaway

ALGN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). XRAY leads in 1 (Valuation Metrics). 1 tied.

Best OverallAlign Technology, Inc. (ALGN)Leads 2 of 6 categories
Loading custom metrics...

MLSS vs NVST vs XRAY vs ALGN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MLSS or NVST or XRAY or ALGN a better buy right now?

For growth investors, Envista Holdings Corp (NVST) is the stronger pick with 8.

3% revenue growth year-over-year, versus -12. 2% for Milestone Scientific Inc. (MLSS). Align Technology, Inc. (ALGN) offers the better valuation at 29. 8x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Align Technology, Inc. (ALGN) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MLSS or NVST or XRAY or ALGN?

On trailing P/E, Align Technology, Inc.

(ALGN) is the cheapest at 29. 8x versus Envista Holdings Corp at 86. 7x. On forward P/E, DENTSPLY SIRONA Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — MLSS or NVST or XRAY or ALGN?

Over the past 5 years, Envista Holdings Corp (NVST) delivered a total return of -46.

6%, compared to -80. 9% for Milestone Scientific Inc. (MLSS). Over 10 years, the gap is even starker: ALGN returned +123. 3% versus MLSS's -80. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MLSS or NVST or XRAY or ALGN?

By beta (market sensitivity over 5 years), Milestone Scientific Inc.

(MLSS) is the lower-risk stock at 0. 85β versus DENTSPLY SIRONA Inc. 's 1. 70β — meaning XRAY is approximately 101% more volatile than MLSS relative to the S&P 500. On balance sheet safety, Align Technology, Inc. (ALGN) carries a lower debt/equity ratio of 3% versus 184% for DENTSPLY SIRONA Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MLSS or NVST or XRAY or ALGN?

By revenue growth (latest reported year), Envista Holdings Corp (NVST) is pulling ahead at 8.

3% versus -12. 2% for Milestone Scientific Inc. (MLSS). On earnings-per-share growth, the picture is similar: Envista Holdings Corp grew EPS 104. 3% year-over-year, compared to 0. 5% for Align Technology, Inc.. Over a 3-year CAGR, ALGN leads at 2. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MLSS or NVST or XRAY or ALGN?

Align Technology, Inc.

(ALGN) is the more profitable company, earning 10. 2% net margin versus -54. 6% for Milestone Scientific Inc. — meaning it keeps 10. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALGN leads at 15. 3% versus -78. 3% for MLSS. At the gross margin level — before operating expenses — MLSS leads at 74. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MLSS or NVST or XRAY or ALGN more undervalued right now?

On forward earnings alone, DENTSPLY SIRONA Inc.

(XRAY) trades at 7. 7x forward P/E versus 17. 0x for Envista Holdings Corp — 9. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XRAY: 25. 5% to $13. 75.

08

Which pays a better dividend — MLSS or NVST or XRAY or ALGN?

In this comparison, XRAY (5.

9% yield) pays a dividend. MLSS, NVST, ALGN do not pay a meaningful dividend and should not be held primarily for income.

09

Is MLSS or NVST or XRAY or ALGN better for a retirement portfolio?

For long-horizon retirement investors, Milestone Scientific Inc.

(MLSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85)). Envista Holdings Corp (NVST) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MLSS: -80. 4%, NVST: -13. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MLSS and NVST and XRAY and ALGN?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MLSS is a small-cap quality compounder stock; NVST is a small-cap quality compounder stock; XRAY is a small-cap income-oriented stock; ALGN is a mid-cap quality compounder stock. XRAY pays a dividend while MLSS, NVST, ALGN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MLSS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Gross Margin > 43%
Run This Screen
Stocks Like

NVST

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

XRAY

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 29%
  • Dividend Yield > 2.3%
Run This Screen
Stocks Like

ALGN

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MLSS and NVST and XRAY and ALGN on the metrics below

Revenue Growth>
%
(MLSS: 25.3% · NVST: 14.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.